PTEN and neoplasm: In RCCs, aggressive tumours are known to show a metabolic shift in which there is downregulation of the TCA cycle genes, decreased levels of AMPK and PTEN protein, upregulation of the pentose phosphate pathway, and glutamine transporter genes, and increased enzyme levels for lipid synthesis [32].